Innate Lymphoid Cell (ILC) Nomenclature and Development

Track: BMT Tandem "Scientific" Meeting
Saturday, March 1, 2014, 8:30 AM-10:00 AM
Texas B+D (Gaylord Texan)
Michael A. Caligiuri, MD , Comprehensive Cancer Center, James Cancer Hospital, The Ohio State University, Columbus, OH
Audio File Recorded Presentation
Disclosures:
M. A. Caligiuri, Innate Pharma, Board Member: Supervisory Board Member
See more of: Innate Immunity and Transplantation
See more of: BMT Tandem "Scientific" Meeting
<< Previous Presentation | Next Presentation >>